Skip to content

Advertisement

BMC Complementary and Alternative Medicine

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Flavonoids from Tetracera indica Merr. induce adipogenesis and exert glucose uptake activities in 3T3-L1 adipocyte cells

  • Md. Mahmudul Hasan1,
  • Qamar Uddin Ahmed1Email author,
  • Siti Zaiton Mat Soad1,
  • Jalifah Latip3,
  • Muhammad Taher2,
  • Tengku Muhamad Faris Syafiq2,
  • Murni Nazira Sarian1,
  • Alhassan Muhammad Alhassan1 and
  • Zainul Amiruddin Zakaria4Email author
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201717:431

https://doi.org/10.1186/s12906-017-1929-3

Received: 10 April 2017

Accepted: 15 August 2017

Published: 30 August 2017

Abstract

Background

Tetracera indica Merr. (Family: Dilleniaceae), known to the Malay as ‘Mempelas paya’, is one of the medicinal plants used in the treatment of diabetes in Malaysia. However, no proper scientific study has been carried out to verify the traditional claim of T. indica as an antidiabetic agent. Hence, the aims of the present study were to determine the in vitro antidiabetic potential of the T. indica stems ethanol extract, subfractions and isolated compounds.

Methods

The ethanol extract and its subfractions, and isolated compounds from T. indica stems were subjected to cytotoxicity test using MTT viability assay on 3T3-L1 pre-adipocytes. Then, the test groups were subjected to the in vitro antidiabetic investigation using 3T3-L1 pre-adipocytes and differentiated adipocytes to determine the insulin-like and insulin sensitizing activities. Rosiglitazone was used as a standard antidiabetic agent. All compounds were also subjected to fluorescence glucose (2-NBDG) uptake test on differentiated adipocytes. Test solutions were introduced to the cells in different safe concentrations as well as in different adipogenic cocktails, which were modified by the addition of compounds to be investigated and in the presence or absence of insulin. Isolation of bioactive compounds from the most effective subfraction (ethyl acetate) was performed through repeated silica gel and sephadex LH-20 column chromatographies and their structures were elucidated through 1H–and 13C–NMR spectroscopy.

Results

Four monoflavonoids, namely, wogonin, norwogonin, quercetin and techtochrysin were isolated from the T. indica stems ethanol extract. Wogonin, norwogonin and techtochrysin induced significant (P < 0.05) adipogenesis like insulin and enhanced adipogenesis like rosiglitazone. Wogonin and norwogonin also exhibited significant (P < 0.05) glucose uptake activity.

Conclusion

The present study demonstrated that the flavonoids isolated from the T. indica stems possess antidiabetic potential revealing insulin-like and insulin-sensitizing effects which were significant among the compounds. This also rationalizes the traditional use of T. indica in the management of diabetes in Malaysia.

Keywords

Tetracera indica Merr.Flavonoids3T3-L1 preadipocyte cellsAdipogenesis2-NBDG glucose uptake activityInsulin like activityInsulin sensitizing activity

Background

Diabetes mellitus (DM) is a very old disease which was reported by the ancient Egyptians more than 300 years ago. Diabetes is a metabolic disorder which is caused by partial or complete absence of insulin or insulin resistance. At present time, occurrence of diabetes has become a major global health issue because of its alarming prevalence all over the world. It is projected that about 20% of the world’s population is liable to become diabetic over the next 10 years. According to the Center for Disease Control and Prevention (CDC, USA), 29.1 million people in the United States of America have diabetes, which is 9.3% of their total population. World’s major pharmaceutical industries are in a race to fight against the chronic complications of diabetes and are coming up with different forms of insulin and insulin mimetics [1].

For type-2 diabetes mellitus (T2DM), several types of therapeutic approaches are taken into account, viz., improving insulin secretion by the pancreas, ameliorating the sensitivity of insulin to target receptor or increasing glucose uptake in adipocyte cells. In recent times, research works on adipocytes have been growing immensely. In vitro research studies for insulin and insulin mimetics exploit the concept to use glucose uptake method using adipocytes for these bioassays. Consequently, adipocytes have been emerging as an important drug target for diabetes and obesity-mediated metabolic syndrome. Adipose tissue, or fat, is an anatomical term for loose connective tissue composed of adipocytes, is not only known for its capability to store the excess of dietary energy in the form of triglycerides, but has also been regarded to play a key role in the regulation of energy metabolism. Adipogenesis is a complex process whereby pre-adipocytes become mature adipocytes with hundreds of genes alterations in the presence of insulin. A number of transcriptional factors have been widely recognised as being involved in the manifestation of adipogenesis, glucose uptake, and glycolysis pathway. These transcription factors mainly include adipokines for example leptin, glucose transporter-4 (GLUT4) and peroxisome proliferator-activated receptor-γ (PPARγ). A morphological alteration from fibroblastic to spherical occurs in the very first step of the adipogenesis when the alteration of the cell shape is accompanied by changes in the level of cytoskeletal and extra cellular matrix (ECM) components [2]. Morphological change of cells, gene expression and lipid accumulation occur gradually by the proteolytic reaction of the stromal ECM [3]. Finally, an elevated enzymatic activity in protein and mRNA level take place which includes the increased insulin sensitivity as well as the glucose transporters [4]. Hence, these transcription factors serve as model systems for evaluating the differentiating program in normal conditions or in conditions of diabetes, insulin resistance and obesity [5].

The search for a new class of safe antidiabetic agents is regarded as an important scientific endeavour to overcome chronic diabetes and its related infirmities. Therefore, there have always been continuous searches for alternative drugs. Ethnomedicinal plants have been recognised as the best source to obtain a variety of drugs according to the World Health Organization [6]. With respect to discard the hypoglycaemic side effect along with other deleterious effects of synthetic drugs, multitudinous ethnomedicinal plants are considered as the point of interest to ethno-botanical community as they have been proved to exhibit important medicinal properties including hypoglycaemic and anti-hyperglycaemic effects [7]. In this regard, many ethnomedicinal plants have been subjected to numerous scientific investigations and have proved extremely beneficial in providing medicinally active agents with desired pharmacological properties to treat the ailments such as type-1 DM and type-2 DM [8].

Presently, scientists have become more fascinated towards ethnomedicinal plants around the world and a numerous biological studies are currently undergoing in regard to discover safe and effective antidiabetic agents from natural sources. In this regard, Tetracera indica (Houtt. Ex Christm. & Panz.) Merr. (Dilleniaceae) is one of the Malaysian medicinal plants to address this issue effectively. It is a large, woody, rain forest climber of Malaysia which is commonly known as Mempelas paya or sand paper plant. It has white coloured flowers and leaves are simple and medium shaped. It has berry-like fruits which are sour in taste [9]. Different parts of the T. indica Merr. have been used for healing fever, flu, sinus symptoms, skin rashes, itching, piles, mouth ulcer, diarrhoea, insects bites and diabetes. T. indica is also used as one of the active ingredients in a local herbal drug viz., Plantisol®, which is widely prescribed and recommended to effectively manage diabetes in Malaysia by the local herbalist practitioners. Barringtonia racemosa, Pithecellobium jiringa, Tinospora crispa and Andrographis paniculata are the other active ingredients of Plantisol® [10]. The in vitro antidiabetic investigation of the aqueous extract of T. indica leaves has already been reported to decrease triglycerides accumulation on 3T3-L1 cells in a dose-dependent manner whereas cells treated with methanol extract significantly induced lipid accumulation. Moreover, both the polar extracts have been further reported to exhibit significant bioactivity in the in vitro 2-deoxy-D-[3H] glucose uptake test which proves its potential of being an antidiabetic agent [11]. However, active principles responsible for its antidiabetic effect are yet to be isolated, ascertained and thoroughly evaluated for their antidiabetic potential. Hence, in this research, our aim was to evaluate an in vitro antidiabetic potential of the T. indica stems ethanol extract and isolated compounds with respect to find out safe and efficacious antidiabetic agents.

Methods

Instruments

Melting points were recorded on a STUART SCIENTIFIC SMP10 instrument. The UV spectra were recorded on a Double beam UV-Visible Spectrophotometer 1700 (SHIMADZU Japan). 1H- and 13C–NMR spectra were recorded on an AVANCE III Bruker Spectrometer at 600 and 150 MHz, respectively. TMS was used as internal standard. ESI-MS spectra were taken on Bruker microTOF-Q spectrometer. All solvents from the extracts were evaporated to dryness using a BUCHI rotary evaporator R-200, water bath and freeze dryer (ALPHA 1–4 LD-2). The dried plant material was pulverised using Fritsch Universal Cutting Mill-Pulverisette 19-Germany. TECAN micro detection microplate reader (M 200) was used to measure the absorbance. Perkin Elmer Multi label HTS reader was used for detecting fluorescent absorbance of 2-NBDG. Evos Microscope and Dino Eye were used for taking pictures of the cells.

Collection and preparation of plant material

Fresh stems (10 kg) of T. indica were collected from the local garden Taman Pertanian, Indera Mahkota, 25,200 Kuantan, Pahang DM, Malaysia. Identification of the plant was performed by the taxonomists of Taman Pertanian and Kulliyyah of Pharmacy, IIUM. Afterward, the sample was deposited in the herbarium of Kulliyyah of Pharmacy to obtain voucher specimen number (NMPC-QSTI-39) for the future references. The same plant material was compared with the already deposited specimen of the same plant.

Ten kg well cleaned fresh stems were dried in a laboratory dryer within a temperature range (30 to 40 °C) and were pulverized to a crude powdered form by applying Fritsch Universal Cutting Mill PULVERISETTE 19 (Germany) and the grinded material was made ready for the extraction process 4.7 kg (47%) to prepare ethanol extract as well as to isolate bioactive compounds [12, 13].

Preparation of ethanol extract, fractionation and isolation of bioactive compounds

The stems powder (4.7 kg) was initially defatted using petroleum ether (b.p. 40–60 °C) and then extracted by soaking in 95% ethanol in a round bottom flask for 24 h at room temperature, filtered through Buchner funnel and finally concentrated in a reduced pressure using Buchi rotary evaporator. Recovered ethanol was again poured into the already extracted powdered material and then refluxed on the water bath for another 2–3 h. This process was repeated about 4 times till the plant material stopped giving colour to ensure maximum yield of ethanol soluble compounds from the powdered stems. The ethanol extract was eventually freeze-dried giving a final yield of 295.5 g EtOH extract (6.28%).

Fractionation of the ethanol extract was done using separatory funnel. Typically, dried ethanol extract (295.5 g) was dissolved in distilled water and treated with hexane until the hexane portion became clearly separated or visible. Collected hexane portion was recovered through rotary evaporator. The combined hexane fraction (11.2 g) was considered as non-polar extract of the stems of T. indica. Subsequently, the remaining hexane insoluble portion was treated with ethyl acetate (EtOAc) in the same manner. After concentrating through rotary evaporator, the collected fraction was considered as EtOAc fraction (62.28 g) of T. indica stems ethanol extract.

Initially, isolation of biologically active compounds was carried out by silica gel 60 (63–200 μm) column chromatography followed by small preparative column chromatographies containing silica gel 60 (63–200 μm) and sephadex LH 20. All fractions were subjected to repeated column chromatographies to isolate antidiabetic agents of T. indica stems in pure form [13].

In vitro antidiabetic activity

Cell culture materials

Mouse 3T3-L1 fibroblast (CL-173) was obtained from the American Type Culture Collection (ATCC), Virginia, USA. Dulbecco’s-modified Eagle medium (DMEM) (with glucose and without glucose), Tryple Express (trypsin) and human recombinant insulin (4 mg/mL) were purchased from GIBCO, India. 4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) was bought from Ameresco, Solon, Ohio 44,139, USA. Rosiglitazone, Dimethyl Sulfoxide (DMSO) and Oil Red O staining were purchased from Sigma Aldrich, USA. 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose (2-NBDG) was obtained from Molecular Probes by Life Technologies, USA. Black microplates were collected from SPL Life Science Limited, Korea and 96 well flat bottom sterile microplates were bought from Greiner Bio-one Cellstar. Phosphate Buffered Saline (PBS) was purchased from GIBCO by Life Technologies, Invitrogen, USA. 3-isobutyl-1-methylxanthine (IBMX) was purchased from EMD Millipore Corp., USA. Dexamethasone was bought from Calbiochem, EMD Chemicals, Inc. San Diego, CA.

Cell culture

3T3-L1 mouse pre-adipocyte cells were cultured according to the protocol provided by the ATCC, Rockville, MD, USA. The growth media was used as DMEM containing 4.5 g/L D-glucose and L-Glutamine with no sodium pyruvate and it was completed by adding 1% penicillin-streptomycin and 5% Fetal Bovine Serum (FBS). The cells were cultured in Greiner-bio CellStar flask of 25 and 75 cm2. The cells were incubated in humidified atmosphere with 5% CO2 supply at 37 °C. The media was changed after every two days and the cells were subcultured upon 80% confluence.

Cell viability assay

The viability assay was carried out to determine any possible adverse effects of extract, fractions and isolated compounds on the 3T3-L1 mouse pre-adipocyte cells. Cell viability was evaluated through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Maximum non-toxic concentration for each extract, fractions and isolated compounds in every bioassay was selected to maximize the potential biological activity while minimizing the potential toxic effects. The maximum non-toxic concentration was determined by treating 3T3-L1 pre-adipocyte cells with extract concentrations ranging from 0.78 to 100 μg/mL for 48 h and assessing cell percent viability. 3T3-L1 pre-adipocyte cells (2 × 105 cells) were seeded in 96-well plates and allowed to get confluent for 48 h. Subsequently, they were treated with extract, fractions and isolated compounds (dose: 0.78–100 μg/ml) for 48 h. Later, the cells were treated with MTT at 5 mg/ml. Every well was treated with 20 μL of MTT and incubated for 4 h. Finally, 100 μL of DMSO was transferred to every well to dissolve the water-insoluble purple formazan crystals [14]. Plates were kept at normal temperature wrapped in the aluminum foil. Absorbance values were measured by TECAN micro detection microplate reader (M 200) at 570 nm.

Cell percent viability (%) = [(mean A sample- mean A blank) / (mean A control-mean blank)] X 100.

Adipogenesis

Induction of Adipogenesis

Insulin is a potent adipogenic hormone that triggers an induction of a series of transcription factors governing differentiation of pre-adipocytes into mature adipocytes. The transformation of the pre-adipocytes to mature adipocytes is known as adipogenesis or differentiation. The adipogenesis was induced according to the protocol reported previously [12, 13, 15, 16]. Briefly, the pre-adipocytes were seeded in 96 well flat bottom sterile microplates. Later, the same cells were treated with the adipogenic cocktail after two days upon 90% confluence. The day was considered as day zero. At the end of the adipogenesis period, more than 90% of the cells contained lipid droplets that could be viewed under low power magnification. This protocol [15] was slightly altered for the adipogenesis experiment, whereby adipogenesis was initiated 2 days post-confluence and total adipogenesis time was 5 to 6 days instead of 6–8 days. The adipogenic cocktail (differentiation media, DM) was modified by insulin, compound/extract and rosiglitazone. Adipogenesis of fibroblasts into mature adipocytes was confirmed by Oil Red O staining (Table 1).
Table 1

Adipogenic cocktail

Group

IBMX

Dexamethasone

Insulin

Rosiglitazone

Compounds

Negative control

------

------------

--------

--------

--------

Control

0.5 mM

1 μM

10 μg/ml

--------

---------

Positive control

0.5 mM

1 μM

10 μg/ml

10 μM

--------

Insulin like activity

0.5 mM

1 μM

---------

--------

Three different concentrations

Insulin-sensitizing activity

0.5 mM

1 μM

10 μg/ml

-------

Three different concentrations

Three different concentrations of wogonin (12.5, 25 and 50 μg/ml), norwogonin (25, 50 and 100 μg/ml) and techtochrysin (12.5, 25 and 50 μg/ml) were determined according to the safety of the cells initially confirmed through MTT assay. The 3T3-L1 pre-adipocytes were incubated for 2 days in the differentiation media. On ‘day 2’, the media was changed to insulin media (IM) (viz. 10 μg/mL insulin in DMEM) for 2 days. Finally, on day 4, the DMEM was applied and was changed in every 2 days for 6–8 days.

Oil red O staining

Oil Red O (Sudan Red 5B, C26H24N4O) is a lysochrome (fat-soluble dye) diazo dye generally used to stain lipids and neutral triglycerides on frozen sections. It is red powder with maximum absorption observed at 518 nm. After adipogenesis, the cells were fixed with 10% formalin in phosphate-buffered saline (PBS) for 1 h at room temperature. Afterwards, the cells were washed 3 times with PBS and stained with freshly prepared Oil Red O (3 parts of Oil Red O of 0.6% in 2 parts of deionized water) from the stock solution for 1 h. Cells were again washed with distilled water and approximately 1 mL isopropanol was further added. Oil Red O staining was extracted by isopropanol after 5 min. Finally, the absorbance was measured using microplate reader at 520 nm [15].

2-NBDG uptake in 3T3-L1 adipocyte cells

2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose, C12H14N4O8) is a fluorescent glucose analog which is used to screen glucose uptake in live cells, as an indicator of cell viability. 2-NBDG typically displays excitation/emission maxima of ~465/540 nm and can be visualized using optical filters designed for fluorescein. To determine whether ethanol extract, fractions and isolated compounds could exert insulin-like or insulin-sensitizing effects on glucose uptake, 3T3-L1 adipocytes were treated with the maximum non-toxic concentrations of ethanol extract, sub-fractions and isolated compounds to stimulate 2-NBDG in the absence and presence of insulin and rosiglitazone (insulin-sensitizer). The 2-NBDG uptake test was carried out by following the protocol described by Alonso-Castro et al. with some modifications [17]. Briefly, the pre-adipocytes were treated with the adipogenic cocktail to differentiate into mature adipocytes using the same protocol used for adipogenesis control group. When the adipogenesis had been completed on day 8, the adipocytes were incubated in DMEM (serum and glucose free) for two days. Afterwards, the serum and glucose starving adipocytes were treated with 80 μM 2-NBDG and sample (in different concentrations) with insulin (10 μg/mL) or with rosiglitazone (10 μM) for 48 h. At the same time, sample was seeded with insulin to investigate the possible insulin-sensitizing effect. The cultures were washed with PBS to get rid of free 2-NBDG upon finishing the incubation. Finally, the fluorescence retained in the cell monolayer was measured by fluorescence microplate reader (Perkin Elmer Multi label HTS reader) at 485 nm (excitation wavelength) and 535 nm (emission wavelength), respectively. The 100% specific 2-NBDG uptake was determined by subtracting control having 2-NBDG and DMEM from control having 2-NBDG and insulin (Table 2).
Table 2

2-NBDG uptake groups

Groups

Cells

Insulin

2-NBDG

Rosiglitazone

Compounds

Negative control

3T3-L1 preadipocytes

---------

80 μM

---------

---------

Control

3T3-L1 adipocytes

10 μg/ml

80 μM

---------

---------

Positive control

3T3-L1 adipocytes

10 μg/ml

80 μM

10 μM

------------

Insulin-like activity

3T3-L1 adipocytes

---------

80 μM

---------

Three different concentrations

Insulin-sensitizing activity

3T3-L1 adipocytes

10 μg/ml

80 μM

10 μM

Three different concentrations

100% specific absorbance = (Absorbance of insulin induced 2-NBDG uptake - Absorbance of non-insulin induced 2-NBDG uptake).

Statistical analysis

Data were interpreted using IBM SPSS (version 20) and a minimum of three (n = 3) replicates were performed for each data on different days. Graphical representations of all data were done by Microsoft Excel. The analysis was done by one-way ANOVA post hoc and followed by dunnett multiple comparison test. The untreated control was taken as dependent variable and rest of the groups were compared with it. A *p < 0.05 was considered statistically significant and **p < 0.005 was considered highly significant.

Results

The in vitro antidiabetic activity of the isolated monoflavonoids from T. indica stems ethanol extract as well as their safe nature (non-toxic behavior evaluated through MTT assay on adipocytes) using in vitro diabetic model are being reported for the first time through this research study Fig. 1 depicts the flow chart of the current study.
Fig. 1

Chemical structure of wogonin (MHQ-1), norwogonin (MHQ-2), quercetin (MHQ-3) and techtochrysin (MHQ-4)

Isolation and structure characterization of bioactive compounds

Active fraction (ethyl acetate fraction) of T. indica stems ethanol extract using repeated silica gel and sephadex LH 20 column chromatographies afforded four different monoflavonoids viz., MHQ-1 (wogonin), MHQ-2 (norwogonin), MHQ-3 (quercetin) and MHQ-4 (techtochrysin) (Fig. 2). These compounds were identified by spectroscopic analysis. Their spectral data were further evaluated and compared with the previously reported spectral data of the similar compounds already isolated from different plants.
Fig. 2

Oil-red-O staining of 3T3-L1 adipocytes on day 10. Results showed to induce differentiation at indicated concentrations in the presence or absence of insulin (10 μg/mL). Cultures in basal medium and insulin served as positive control. Cells treated with rosiglitazone served as drug control

MHQ-1 (Wogonin): Yellow crystal; mp: 205–206 °C; U.Vmax nm MeOH: (MeOH only): 211.7, 276; (MeOH/NaOMe, immediately): 242, 284, 381; (MeOH/NaOMe, after ten min): 242, 284.5, 381.50; (MeOH/NaOAc): 243, 284, 381; (MeOH/NaOAc/H3BO3): 279, 351; (MeOH/AlCl3): 284.50, 325.1, 404.7; (MeOH/AlCl3/HCl): 287, 329, 403.5; (MeOH/NaOH): 242, 286.50, 380; IR (KBr) ν max cm−1: 3190, 2923, 2860, 1732, 1656, 1607, 1578, 1559, 1508, 1451, 1414, 1355, 1325, 1298, 1264, 1248, 1206, 1112, 1161, 1112, 1019, 987, 842, 787, 763, 682, 671, 661, 556; 1H–NMR [600 MHz, Acetone-d6,δ (ppm)]: δ 6.835 (s, 1H, H-3), δ 6.349 (s, 1H, H-6), δ 8.136 (m, 2H, H-2′/H-6′), δ 7.653 (m, 3H, H-3′/H4′/H5′), δ 3.983 (s, OCH3, 3H, H-8a), 12.591 (s. 1H, OH-5); 13C–NMR [150 MHz, Acetone-d6, δ (ppm)]: δ 157.34 (C-2), δ 105.18 (C-3), δ 182.42 (C-4), δ 157.15 (C-5), δ 99.00 (C-6), δ 163.59 (C-7), δ 127.93 (C-8), δ 149.91 (C-9), δ 104.48 (C-10), δ 131.42 (C-1′), δ 129.25 (C-2′), δ 126.37 (C-3′), δ 131.95 (C-4′), δ 126.37 (C-5′), δ 129.25 (C-6′), δ 61.07 (C-8a); ESI-MS m/z 284 [M]+; 283 [M-H]; 285 [M + H]+ corresponding to (C16H12O5) [18].

MHQ-2 (Norwogonin): Golden yellow crystal; mp: 258–260 °C; U.Vmax nm MeOH: (MeOH only): 276.50; (MeOH/NaOMe, immediately): 377, 282.50, 242.50; (MeOH/NaOMe, after 10 min): 377, 283, 244; (MeOH/NaOAc): 372, 283, 243; (MeOH/NaOAc/H3BO3): 279, 241; (MeOH/AlCl3): 291.50, 248.50; (MeOH/AlCl3/HCl): 291.50, 249.50; (MeOH/NaOH): 377.50, 284.50, 242.50;IR (KBr) ν max cm−1: 3283.70, 3060.50, 2356.10, 1650.89, 1595.64, 1573.38, 1549.28, 1520.32, 1445.31, 1415.84, 1369.73, 1321.16, 1261.95, 1242.98, 1207.05, 1176.24, 1157.89, 1011.02, 956.88, 833.22, 773.96, 718.28, 676.83, 661.83, 566.38, 503.53, 470.78; 1H–NMR [600 MHz, MeOD-d4,δ (ppm)]: δ 6.783 (s, 1H, H-3), 6.365 (s, 1H, H-6), 7.635 (m, 3H, H-3′/H4′/H5′), 8.165 (m, 2H, H-2′/H-6′), 12.356 (s, 1H, OH-5); 13C–NMR [150 MHz, MeOD-d4, δ (ppm)]: δ 153.17 (C-2), 104.98 (C-3), 184.54 (C-4), 154.54 (C-5), 98.65 (C-6), 163.62 (C-7), 131.51 (C-8), 145.67 (C-9), 104.21 (C-10), 124.88 (C-1′), 129.00 (C-2′, C-6′), 126.56 (C-3′, C-5′), 131.75 (C-4′); ESI-MS m/z 270 [M + H]+; 269 [M-1H] corresponding to C15H10O5 [19].

MHQ-3 (Quercetin): Yellow crystal, mp: 315–316 °C; U.Vmax nm: (MeOH only): 242.50, 281, 330; (MeOH/NaOMe, immediately): 243.50, 280.50, 331.50; (MeOH/NaOMe, after 10 mins.) 246, 333; (MeOH/NaOAc): 255.50, 376.50; (MeOH/NaOAc/H3BO3): 259, 298.50, 386; (MeOH/AlCl3) 222, 264.50; (MeOH/AlCl3/HCl): 222, 266.50, 362.50; (MeOH/NaOH) 219, 255, 370; IR (KBr) ν max cm−1: 3257.4, 1660.9, 1603.2, 1558.5, 1519.3, 1447.0, 1407.4, 1378.2, 1316.3, 1258.7, 1213.5, 1196.2, 1165.3, 1130.3, 1091.4, 1013.6, 840.7, 818.7, 794.6, 782.7, 720.4, 672.4, 636.9, 601.5, 488.8; 1H–NMR [600 MHz, Acetone-d6,δ (ppm)]: δ 6.260 (d, J = 2.4 Hz, 1H, H-6), 6.516 (d, J = 1.8, 1H, H-8), 6.997 (d, J = 8.4 Hz, 1H, H-5′), 7.700 (dd, J = 1.8, 8.4 Hz, 1H, H-6′), 7.819 (d, J = 2.4 Hz, 1H, H-2′), 12.45 (1H, s, OH-5); 13C–NMR [150 MHz, Acetone-d6, δ (ppm)]: 175.60 (C-4), 164.07 (C-7), 161.18 (C-5), 156.88 (C-9), 147.36 (C-4′), 146.00 (C-2), 144.86 (C-3′), 135.81 (C-3), 122.84 (C-1′), 120.56 (C-6′), 115.33 (C-5′), 114.78 (C-2′), 103.17 (C-10), 98.17 (C-6), 93.56 (C-8); ESI-MS m/z 301 [M-2H], 303 [M + H]+ corresponding to C15H10O7 [20].

MHQ-4 (Techtochrysin) (5-hydroxy-7-methoxyflavone): Light greenish yellow crystal; mp: 295 °C; U.Vmax nm MeOH: (MeOH only): 237, 271, 354; (MeOH: NaOMe, immediately): 351.50; (MeOH/NaOMe, after ten min): 357.50; (MeOH/NaOAc): 236.50, 266.50, 349.50; (MeOH/NaOAc/H3BO3): 260.50, 317; (MeOH/AlCl3): 252, 310.50; (MeOH/AlCl3/HCl): 264; (MeOH/NaOH): 255.50, 314; IR (KBr) ν max cm−1: 3093.0, 1633.2, 1582.0, 1569.1, 1510.7, 1494.6, 1465.4, 1432.5, 1395.7, 1310.5, 1264.4, 1243.0, 1220.0, 1166.1, 1116.9, 1101.4, 1049.9, 993.0, 960.0, 909.3, 843.6, 797.3, 759.7, 685.7, 670.7, 670.7, 537.2, 498.6; 1H–NMR [600 MHz, MeOD-d4, δ (ppm)]: δ 6.68 (s, 1H, H-3), 6.45 (d, J = 2.4 Hz, 1H, H-6), 6.60 (d, J = 2.4, 1H, H-8), 7.97 (dd, J = 1.8,4.2 Hz, 2H, H-2′/H-6′), 7.58 (m, 3H, H-3′/H-4′/H5′), 3.90 (s, 3H, 7-OCH3); 13C–NMR [150 MHz, MeOD-d4, δ (ppm)]: 162.72, 108.73, 180.23, 163.32, 97.87, 165.57, 96.66, 161.58, 108.50, 132.68, 130.37, 127.35, 132.88, 127.35, 130.37, 56.64; ESI-MS m/z 268 [M + H]+, 267 [M-1H] corresponding to C16H12O4 [21].

In vitro bioactivity determination

MTT assay

MTT viability assay was performed on 3T3-L1 pre-adipocytes to assess the safety of the plant’s ethanol extract, sub-fractions and isolated compounds. In this study, the IC50 (concentration at which sample kills 50% of the cells) was considered the safe concentration (viz. isolated compounds, extracts and fractions) for the adipocyte cells in order to assess antidiabetic evaluation of test substances. The concentrations at which more than 50% cells found to be alive were selected for an in vitro antidiabetic evaluation. Eight concentrations of each sample (0.78 to 100 μg/mL) had been used to check whether it were safe to the adipocytes cells or not. Results suggested that the T. indica stems ethanol extract inhibited 18.60% cells at its highest concentration (100 μg/mL) which was found to be highly significant (**p < 0.005) in comparison to the control group. So, the ethanol extract was considered safe for the cells at its highest concentration (viz. 100 μg/mL). Similarly, both fractions (hexane and ethyl acetate) were also found to be safe at their highest concentrations viz. 35.27% and 21.40%, respectively, and both varied from the control significantly (**p < 0.005 inhibition) (Table 3).
Table 3

MTT viability assay results

Sample

Dose

% Inhibition

Ethanol (95%) extract

100 μg/mL

18.60

Hexane fraction

100 μg/mL

35.27

Ethyl acetate fraction

100 μg/mL

21.39

MHQ-1 (Wogonin)

25 μg/mL

51.96

MHQ-2 (Norwogonin)

100 μg/mL

22.64

MHQ-3 (Quercetin)

100 μg/mL

25.48

MHQ-4 (Techtochrysin)

50 μg/mL

49.39

Phenolic compounds isolated from the ethyl acetate fraction of T. indica stems ethanol extract viz. wogonin (MHQ-1) showed IC50 at 25 μg/mL (51.97% inhibition) and techtochrysin (MHQ-4) showed IC50 at 50 μg/mL (49.40% inhibition). However, the remaining two phenolic compounds (norwogonin and quercetin) were found to be safe up to 100 μg/mL. The percent inhibitions at their highest concentrations of norwogonin (MHQ-2) and quercetin (MHQ-3) were found to be 22.75% and 25.48%, respectively. So, it was concluded that these compounds up to 100 μg/mL can be safely used to evaluate bioactivity due to their safe profile at the tested concentration through MTT assay.

Adipogenesis

In this experiment, ethanol extract of the stems of T. indica’s stems ethanol extract, its sub-fractions and isolated phenolic compounds from the bioactive fraction were evaluated in order to check whether they can induce adipogenesis in the presence and absence of insulin. Rosiglitazone was taken as positive control which was technically used as a marker for insulin-sensitizing activity of the samples. The results showed that the T. indica stems ethanol (95%) extract, ethyl acetate fraction and three of the four phenolic compounds (MHQ-1, MHQ-2 & MHQ-4) showed effects in a dose-dependent manner similar to insulin- like activity and also insulin sensitizing activity. However, non-polar fraction (hexane fraction) and quercetin (MHQ-3) showed no effect on stimulating adipogenesis without insulin. Moreover, both did not exert any insulin sensitizing effect in comparison to rosiglitazone (Figs. 3, 4 and 5).
Fig. 3

T. indica stems ethanol extract, two fractions (hexane and ethyl acetate) and isolated four phenolic compounds (MHQ-1, MHQ-2, MHQ-3, MHQ-4) were investigated for their ability to enhance adipogenesis in the absence and presence of insulin (10 μg/mL) and rosigiltazone (10 μM). The results showed in absorbance (Mean ± SD), n = 3 per group and triplicate of each group

Fig. 4

T. indica stems ethanol extract, two fractions (hexane and ethyl acetate) and four phenolic compounds (MHQ-1, MHQ-2, MHQ-3, MHQ-4) were investigated for their ability to enhance adipogenesis in the absence and presence of insulin (10 μg/mL) and rosigiltazone (10 μM) at three different safe concentrations obtained according to MTT viability assay (12.5–50 μg/mL). Cells in DMEM without any treatment were considered as untreated control. Cells treated with insulin and rosiglitazone were taken as insulin control and positive control. Data expressed in percentage (rosiglitazone was taken as 100%) mean ± SD, n = 9 (biological triplicate each containing n = 3). One-way ANOVA showed significant value, **p < 0.005

Fig. 5

Wogonin (MHQ-1), norwogonin (MHQ-2) and techtochrysin (MHQ-4) were evaluated to stimulate 2-NBDG uptake in 3T3-L1 adipocytes in the absence and presence of insulin at indicated concentration 12.5–100 μg/mL, respectively. Cultures in basal medium and insulin served as control. Cells treated with rosiglitazone were considered as positive control which represents insulin-sensitizing activity. Data expressed in mean ± SD, n = 9 (Three biological triplicate each containing minimum n = 3). One-way ANOVA showed significant value, **p < 0.005

Fluorescence glucose uptake

This experiment was designed to evaluate the insulin-like and insulin sensitizing activity for the isolated phenolic compounds. Hence, wogonin, norwogonin and techtochrysin were evaluated on matured adipocytes to stimulate 2-NBDG in the absence and presence of insulin and rosiglitazone (insulin-sensitizer). The results in our study show an increase stimulation of the 2-NBDG uptake in the absence of insulin. It was found out that all three phenolic compounds exerted a dose-dependent effect as the activity was found to increase with the increased concentrations of all three phenolic compounds. Interestingly, it was also found out that 2-NBDG uptake by wogonin was higher than the insulin (control) at its highest concentration i.e. 50 μg/mL. Norwogonin also exhibited 2-NBDG uptake activity higher than the insulin by showing higher fluorescence absorbance at its highest concentration i.e. 100 μg/mL. In the same experiment, rosiglitazone was taken as a positive control to determine insulin-sensitizing effect on 3T3-L1 adipocytes. The results suggested that all three phenolic compounds exert insulin sensitizing effect in a dose-dependent manner. Fluorescence absorbance of the wogonin was slightly less than the rosiglitazone at its highest concentration i.e. 50 μg/mL, however, norwogonin showed more 2-NBDG uptake than the rosiglitazone at its highest concentration i.e. 100 μg/mL. Moreover, techtochrysin also showed 2-NBDG uptake on matured adipocytes, which was, however, less than the wogonin and norwogonin at its highest concentration i.e. 50 μg/mL. Techtochrysin exhibited concentration-dependent 2-NBDG uptake by showing a slightly higher absorbance (0.58) than the insulin at its highest concentration in fluorescence microplate reader. However, techtochrysin did not display any significant insulin sensitizing activity when it was compared with the absorbance of the rosiglitazone (Fig. 6).
Fig. 6

Flow chart of the study

Discussion

Adipocytes are the major site of insulin action and, thereby, play an important role in glucose metabolism as well as in the regulation of whole-body glucose homeostasis. The widespread epidemics of obesity and type-2 diabetes mellitus (T2DM) suggest that both conditions are closely interconnected. The increased incidence of extreme visceral obesity and obesity-related cardiovascular risk factors are closely related to the rising prevalence of cardiovascular diseases and T2DM [12, 13]. The prevalence of obesity has become a chief public health apprehension worldwide. Obesity is described by the accretion of overabundance fat in adipose tissues [22] and increased deposition of cytoplasmic triglycerides, which might lead to various metabolic and chronic ailments such as cardiovascular diseases, T2DM, cancer etc. [23]. The development of obesity in adults is also accompanied by substantial differentiation of preadipocytes into adipocytes [15]. Recently, the research studies on adipocytes have been growing enormously. Consequently, adipocytes are evolving as a major drug target for diabetes and obesity-mediated metabolic syndromes [24]. Adipose tissues are not only recognized for their capacity to store the excess of dietary energy in the form of triglyceride [25], however, they are also known to play a vital role in the regulation of energy metabolism [26, 27]. During the process of adipogenesis, the pre-adipocytes undergo growth arrest and they are differentiated to mature adipocytes. There is a dramatic increase in the adipocyte gene expression during this process which includes adipocyte fatty acid binding proteins, lipid metabolizing enzymes etc. A number of transcription factors have been reported to be engaged in the complex adipogenesis process where glucose uptake and glycolysis pathway are considered noteworthy [28]. These transcription factors include peroxisome proliferator-activated receptor-γ (PPARγ), glucose transporter-4 (GLUT4), and adipokines such as leptin. One of the most important processes of adipogenesis is PPAR-γ activation by the ligands. PPARγ is predominantly expressed in adipose tissues and plays a central role in adipose tissue functions [29]. Moreover, PPAR-γ is responsible for the genes linked to insulin signaling, glucose and lipid metabolism in mature adipocytes [30]. Reduced expression of PPAR훾 has been shown to be effective in inhibiting the adipogenesis of 3 T3- L1 cells [31]. Glucose homeostasis in the body is mainly mediated by translocation of the insulin-responsive glucose transporter GLUT4. An impaired GLUT4 translocation plays a crucial role in the pathogenesis of insulin resistance as one of the earliest events during the development of T2DM. GLUT4 is a high affinity glucose transporter predominantly expressed in insulin-sensitive tissues such as muscle and adipocytes [32]. Increased expression and plasma membrane translocation of GLUT4 have been found to lower blood glucose, enhance glucose transport and utilization [33]. Leptin is produced mainly by adipocytes and also found in low levels in the gastric fundic epithelium, intestine, skeletal muscle, mammary epithelium, placenta, and brain [34]. High levels of circulating leptin in adipose tissues characterize human obesity [35] and increased levels of body fat [36].

3T3-L1 pre-adipocytes after undergoing the differentiation to adipocytes serve as excellent in vitro models and are considered valuable tools in understanding the glucose metabolism. In recent research studies, 3T3-L1 pre-adipocytes have been extensively used for the adipogenesis. The pre-adipocytes are adherent fibroblast-like in shape and they form confluent monolayer. Pre-adipocytes are differentiated into adipocytes through an inducer known as adipogenic cocktail which includes insulin, phosphodiesterase inhibitor methylisobutylxanthine (IBMX), fetal bovine serum (FBS) and the synthetic glucocorticoid dexamethasone [37]. Our study was designed to evaluate the activity by altering the adipogenic cocktail. The insulin like activity of the compounds was determined by replacing the insulin from the adipogenic cocktail and the insulin-sensitizing activity was determined in the presence of insulin to evaluate whether it can sensitize or increase the effect of insulin. In our study, we used T. indica stems ethanol extract, its sub-fractions and isolated compounds from the bioactive fraction in order to check whether they can induce adipogenesis in the presence or absence of insulin. Rosiglitazone, a thiazolidinediones drug, was taken as positive control which is an insulin-sensitizing agent that acts by improving the sensitivity of peripheral tissues to insulin through activating PPAR-γ receptor [38, 39]. The results showed that the T. indica stems ethanol extract, ethyl acetate fraction and three monoflavonoids isolated from the ethyl acetate fraction viz. wogonin, norwogonin and techtochrysin showed effects in a dose dependent manner similar to insulin-like- and insulin sensitizing activities. However, non-polar fraction (hexane fraction) showed no effect on stimulating adipogenesis in the absence of insulin. Moreover, the hexane fraction also did not show any insulin sensitizing effect in comparison to rosiglitazone. Stems ethanol extract, ethyl acetate fraction and three monoflavonoids (wogonin, norwogonin and techtochrysin) at their highest concentration showed absorbance almost similar to control (insulin) and also exhibited similar activity like rosiglitazone.

PPARγ ligands can affect the adipocyte differentiation and are reported to have an effect on glucose uptake in 3T3-L1 adipocytes [39]. Hence, the next objective of this research study was an attempt to assess the effect of isolated compounds on the glucose uptake and insulin sensitizing effects. In adipocytes, basal (cells treated with normal glucose without the presence of insulin and 2-NBDG) and insulin-stimulated glucose uptake activities require a glucose transporter. Insulin can accelerate glucose entry by affecting the translocation of GLUT4 from intracellular stores to the plasma membrane [40]. In general, it is known that GLUT4 provides insulin-stimulated glucose transport in adipocytes [41]. Furthermore, glucose uptake in adipocytes is the consequences of stimulation of insulin receptors by insulin. This process consists of translocation of GLUT4 [42]. During adipogenesis, the expression of GLUT4 is increased and in the presence of insulin, the GLUT4 is translocated to plasma membrane. Subsequently, the glucose uptake by the cells is increased [43]. Moreover, GLUT4 is expressed only in the adipocytes and its expression is regulated by PPARγ. GLUT4, which transports glucose from blood into tissue, is the principal glucose transporter among several isotypes of glucose transporters in insulin-sensitive tissues such as skeletal muscle and adipocytes [44]. Decrease in the translocation of GLUT4 to the plasma membrane has been found to be the principal cause of insulin resistance [45], and therefore, it is required to activate GLUT4 in the skeletal muscle to improve insulin resistance and to maintain blood glucose homeostasis. Metformin, is one of the most commonly prescribed antidiabetic drugs worldwide, can enhance the insulin-stimulated glucose uptake by increasing the GLUT4 content at the cell surface [46]. Rosiglitazone belongs to thiazolidinediones, also known as “glitazones,” binds to peroxisome proliferator-activated receptors (PPARs), a type of nuclear regulatory proteins involved in transcription of numerous genes regulating glucose and fat metabolisms. They act as “insulin sensitizers” without increasing insulin secretion. Thiazolidinediones do not increase insulin release like the sulfonylureas but increase the response to insulin. Our experiments were designed to evaluate insulin-like and insulin sensitizing activities. Flavonoids are a group of polyphenolic compounds which are known to exert a variety of biological effects including antidiabetic effect. Hence, we evaluated all the three monoflavonoids (wogonin, norwogonin and techtochrysin) on the matured adipocytes to stimulate 2-NBDG in the absence and presence of insulin and rosiglitazone (insulin-sensitizer).

MTT viability test helps to determine the safe concentration of the tested compounds used in the bioactivity experiments on pre-adipocytes. Hence, in our research study, a total of 8 different concentrations (doses) were initially evaluated and finally 3 safe doses were selected to evaluate their bioactivities in the experiments. All groups were compared with the untreated control group to check the significant differences. It was observed that the insulin control and rosiglitazone control groups were significantly different from the untreated control group. As the mechanism of action for insulin sensitizer is to increase the insulin activity, we treated rosiglitazone along with insulin to observe the insulin-sensitizing activity. Moreover, the treatment groups without insulin were compared with the insulin groups to understand the insulin-like activity of the groups whereas the groups containing the insulin and sample (compounds/extracts) were compared to rosiglitazone group to check the insulin-sensitizing activity. It was observed that the effect of adipogenesis was manifested in a dose dependent manner. The ethanol extract, ethyl acetate fraction, wogonin, norwogonin and techtochrysin showed insulin like activity. Moreover, ethanol extract, ethyl acetate fraction, wogonin, norwogonin and techtochrysin exhibited activity similar to insulin at their highest dose. The groups also showed same trend when they were compared with rosiglitazone-insulin combination. In contrast, however, the hexane fraction and quercetin showed no significant adipogenesis when they were evaluated without insulin. Additionally, no insulin sensitizing activity was observed with the hexane fraction and quercetin either.

Our study showed an increase stimulation of the 2-NBDG uptake in the absence of insulin. We can see a dose-dependent increase for all the three phenolic compounds. All three compounds (i.e. wogonin, norwogonin and techtochrysin) exerted a dose-dependent activity as the activity was found to increase with the increased concentration of all compounds. Interestingly, it was also observed that, 2-NBDG uptake by wogonin was higher than the insulin control at its highest concentration (50 μg/mL). Same results were manifested by the norwogonin as well. The fluorescence absorbance at the highest concentration i.e., 100 μg/mL was found to be much higher than the insulin. In the same experiment, rosiglitazone was taken as positive control to determine insulin-sensitizing effect on 3T3-L1 adipocytes. The results suggested insulin sensitizing effect on a dose dependent manner for wogonin and norwogonin. Fluorescence absorbance of the wogonin was slightly less than the rosiglitazone at its highest concentration (50 μg/mL), however, norwogonin showed more 2-NBDG uptake than the rosiglitazone at its highest concentration (100 μg/mL). This suggests strong antidiabetic potential for both the monoflavonoid aglycones. Moreover, techtochrysin also exhibited 2-NBDG uptake on matured adipocytes, however, less significant than the wogonin and norwogonin at its highest concentration i.e. 50 μg/mL. Hence, it can be summarised that T. indica stems ethanol extract, ethyl acetate fraction, wogonin, norwogonin and techtochrysin exert insulin sensitizing activity in the same manner as rosiglitazone does and therefore are potential antidiabetic substances.

Conclusion

The present study has shown that wogonin, norwogonin and techtochrysin isolated from T. indica stems ethanol extract possess antidiabetic effect on 3T3-L1 adipocytes. Wogonin and norwogonin were found to reveal significant insulin-like and insulin-sensitizing activities at their safe concentrations during adipogenesis. Furthermore, both monoflavonoids displayed significant increase in stimulating 2-NBDG in the absence of insulin. Norwogonin showed higher 2-NBDG uptake activity than the rosiglitazone. This clearly proves insulin-sensitizing ability of these two monoflavonoids. Our study suggests antidiabetic potential of the isolated compounds of T. indica in terms of insulin-like and insulin-sensitizing effects. However, we still suggest further in depth research study on the isolated compounds that might lead to the discovery of efficacious antidiabetic drugs.

Abbreviations

13C NMR: 

13Carbon nuclear magnetic resonance

1H NMR: 

Proton nuclear magnetic resonance

2-NBDG: 

2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose

ACETONE-D6: 

Deuterated acetone

APT: 

Attached proton test

CDCl3

Deuterated chloroform

DCM: 

Dichloromethane

DM: 

Diabetes mellitus

DMEM: 

Dulbecco’s modified eagle medium

DMSO: 

Dimethyl sulfoxide

DPP: 

Dipeptidyl peptidase

ECM: 

Extra cellular matrix

EtOH: 

Ethanol; FBS: Fetal bovine serum

FTIR: 

Fourier transform infrared spectroscopy

GLUT: 

Glucose transporter

IBMX: 

3-isobutyl-1-methylxanthine

IC50

Inhibitory concentration where the response reduced by half

MOA: 

Mechanism of action

MTT: 

3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium bromide

NHMS: 

National health and morbidity survey

ORO: 

Oil red O staining

PBS: 

Phosphate buffered saline

PPARγ: 

Peroxisome proliferator-activated receptor-γ

PPM: 

Parts per million

SPSS: 

Statistical package for the social sciences

T2DM: 

Type 2 Diabetes Mellitus

TEF: 

Toluene: Benzene: Formic Acid

TLC: 

Thin layer chromatography

Declarations

Acknowledgements

Authors are grateful to the Ministry of Higher Education (MOHE), Malaysia and the Research Management Center, IIUM for financial assistance to accomplish this work. Authors are also grateful to the Molecular Structure Determination Laboratory (MSDL), Centre for Research and Instrumentation Management, University Kebangsaan Malaysia (CRIM, UKM) under the leadership of Dr. Jalifah Latip, for conducting NMR/MS analysis of all compounds.

Funding

This research work was supported under the grant of Fundamental Grant Research Scheme (FRGS 13–089-0330), Research Acculturation Collaborative Effort (RACE14–012-0018) by the Ministry of Higher Education (MOHE), Malaysia and IIUM Research Initiative Grant Scheme (RIGS 16–294-0458 & RIGS 16–288-0452), RMC, IIUM, Malaysia.

Availability of data and materials

The data and materials have been presented in the main manuscript and can be given upon request.

Authors’ contributions

MMH run laboratory experiments and prepared the research manuscript. QUA, SZMS, ZAZ and MT designed, supervised the research work and finalized the research manuscript. JL provided the NMR spectra of all compounds. TMFS, MNS, AMA run an in vitro study to confirm reproducible results and further helped in the analysis of data and proof reading. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia
(2)
Department of Pharmaceutical Technology, Kulliyyah of Pharmacy, International Islamic University Malaysia
(3)
School of Chemical Sciences and Food Technology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia
(4)
Halal Institute Research Institute, Universiti Putra Malaysia

References

  1. Bentley-Lewis R, Xiong G, Lee H, Yang A, Huynh J, Kim C. Metabolomic analysis reveals amino acid responses to an oral glucose tolerance test in women with prior history of gestational diabetes mellitus. J Clin Transl Endocrinol. 2014;1(2):38–43.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78(3):783–809.PubMedGoogle Scholar
  3. Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol. 2001;3(3):267–75.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Zhao L, Gregoire F, Sul HS. Transient induction of ENC-1, a Kelch-related actin-binding protein, is required for adipocyte differentiation. J Biol Chem. 2000;275(22):16845–50.View ArticlePubMedGoogle Scholar
  5. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145–71.View ArticlePubMedGoogle Scholar
  6. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo ZG. Medicinal-plants in therapy. Bull World Health Organ. 1985;63(6):965–81.PubMedPubMed CentralGoogle Scholar
  7. Ponnusamy S, Ravindran R, Zinjarde S, Bhargava S, Kumar AR. Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid Based Complement Alternat Med. 2011. https://doi.org/10.1155/2011/515647.
  8. Li WK, Chen SN, Fabricant D, Fong H, Farnsworth N, Fitzloff J. High performance liquid chromatographic analysis of black cohosh (Cimicifuga racemosa) with in-line photodiode array and evaporative light scattering detection. Abstr Pap Am Chem Soc. 2001;222:U90-U90Google Scholar
  9. Christophe W. Medicinal Plants of Southeast Asia. In: Wong FK, editor. Prentice Hall, vol. 75. 2nd ed. Selangor-Malaysia: Pearson Malaysia Sdn. Bhd.; 2002.Google Scholar
  10. Kencing Manis. http://www.klik4sihat.com/kencingmanis. Accessed 9 Jan 2017.
  11. Ahmed QU, Dogarai BBS, Amiroudine MZAM, Taher M, Latip J, Umar A, Muhammad BY. Antidiabetic activity of the leaves of Tetracera indica Merr.(Dilleniaceae) in vivo and in vitro. J Med Plants Res. 2012;6(49):5912–22.Google Scholar
  12. Yankuzo H, Ahmed QU, Rahajoe IS, Akter SFU, Talib NA. Beneficial effect of the leaves of M. koenigii (L.) Spreng (Rutaceae) on -induced renal damage in vivo. J Ethnopharmacol. 2011;135(1):88–94.Google Scholar
  13. Umar A, Ahmed QU, Muhammad BY, Dogarai BBS, Soad SZM. Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats. J Ethnopharmacol. 2010;131:140–5.View ArticlePubMedGoogle Scholar
  14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.View ArticlePubMedGoogle Scholar
  15. Park JH, Kim RY, Park E. Antidiabetic activity of fruits and vegetables commonly consumed in Korea: inhibitory potential against alpha-glucosidase and insulin-like action in vitro. Food Sci Biotechnol. 2012;21(4):1187–93.View ArticleGoogle Scholar
  16. Zhu HJ, Ding HH, Deng JY, Pan H, Wang LJ, Li NS, Gong FY. Inhibition of preadipocyte differentiation and adipogenesis by zinc-α2-glycoprotein treatment in 3T3-L1 cells. J Diabetes Investig. 2013;4(3):252–60.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Alonso-Castro AJ, Miranda-Torres AC, Gonzalez-Chavez MM, Salazar-Olivo LA. Cecropia obtusifolia Bertol and its active compound, chlorogenic acid, stimulate 2-NBDglucose uptake in both insulin-sensitive and insulin-resistant 3T3 adipocytes. J Ethnopharmacol. 2008;120(3):458–64.View ArticlePubMedGoogle Scholar
  18. Harrison LJ, Sia GL, Sim KY. 5, 7-Dihydroxy-8-methoxyflavone from Tetracera indica. Planta Med. 1994;60:493–494.494.View ArticlePubMedGoogle Scholar
  19. Siddikov GU, Yuldashev MP, Aripova SF, Vdovin AD, Abdullaev ND, Botirov EK. New flavanones from Scutellaria phyllostachya roots. Chem Nat Compd. 2008;44(1):28–30.View ArticleGoogle Scholar
  20. Chang SW, Kim KH, Lee IK, Choi SU, Ryu SY, Lee KR. Phytochemical constituents of Bistorta manshuriensis. Nat Prod Sci. 2009;15:234–40.Google Scholar
  21. Sutthanut K, Sripanidkulchai B, Yenjai C, Jay M. Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora by gas chromatography. J Chromatogr A. 2007;1143(1):227–33.View ArticlePubMedGoogle Scholar
  22. Devalaraja S, Jain S, Yadav H. Exotic fruits as therapeutic complements for diabetes, obesity and metabolic syndrome. Food Res Int. 2011;44(7):1856–65.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Lois K, Kumar S. Obesity and diabetes. Endocrinologia y Nutricion. 2009;56:38–42.View ArticlePubMedGoogle Scholar
  24. Nawrocki AR, Scherer PE. Keynote review: the adipocyte as a drug discovery target. Drug Discov Today. 2005;10(18):1219–30.View ArticlePubMedGoogle Scholar
  25. Eric J, Luc T. Obesity. Mol Asp Med. 1997;18(4):247–305.View ArticleGoogle Scholar
  26. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104(4):531–43.View ArticlePubMedGoogle Scholar
  27. Yun JW. Possible anti-obesity therapeutics from nature-a review. Phytochemistry. 2010;71(14):1625–41.View ArticlePubMedGoogle Scholar
  28. Vázquez-Vela MEF, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res. 2008;39(8):715–28.View ArticlePubMedGoogle Scholar
  29. Brun RP, Spiegelman BM. PPARgamma and the molecular control of adipogenesis. J Endocrinol. 1997;155(2):217–8.View ArticlePubMedGoogle Scholar
  30. Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, Casellas P. Anandamide induced PPAR gamma transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur J Pharmacol. 2005;517(3):174–81.View ArticlePubMedGoogle Scholar
  31. Huang C, Zhang Y, Gong Z. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway. Biochem Biophys Res Commun. 2006;348(2):571–8.View ArticlePubMedGoogle Scholar
  32. Watson RT, Pessin JE. GLUT4 translocation: the last 200 nanometers. Cell Signal. 2007;19(11):2209–17.View ArticlePubMedGoogle Scholar
  33. Akiba T, Yaguchi K, Tsutsumi K. Inhibitory mechanism of caffeine on insulin-stimulated glucose uptake in adipose cells. Biochem Pharmacol. 2004;68(10):1929–37.View ArticlePubMedGoogle Scholar
  34. Tzameli I, Fang H, Ollero M, Shi H, Hamm JK, Kievit P, Flier JS. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem. 2004;279(34):36093–102.View ArticlePubMedGoogle Scholar
  35. Stier RF. Chemistry of frying and optimization of deep-fat fried food flavour - an introductory review. Eur J Lipid Sci Technol. 2000;102(8–9):507–14.View ArticleGoogle Scholar
  36. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129–39.View ArticlePubMedGoogle Scholar
  37. Fu MG, Sun TW, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol Endocrinol. 2005;19(10):2437–50.View ArticlePubMedGoogle Scholar
  38. Ming Y, Hu XN, Song Y, Liu ZG, Li JB, Gao RF, Xiao XQ. CMHX008, a novel peroxisome proliferator-activated receptor gamma partial agonist, enhances insulin sensitivity in vitro and in vivo. Plos One. 2014;9(7):e102102.Google Scholar
  39. Tafuri SR. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Endocrinology. 1996;137(11):4706–12.View ArticlePubMedGoogle Scholar
  40. Thomson MJ, Williams MG, Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem. 1997;272(12):7759–64.View ArticlePubMedGoogle Scholar
  41. Shang W, Yang Y, Jiang B, Jin H, Zhou L, Liu S, Chen M. Ginsenoside Rb 1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARγ 2 and C/EBPα gene expression. Life Sci. 2007;80(7):618–25.View ArticlePubMedGoogle Scholar
  42. Song EK, Lee YR, Kim YR, Yeom JH, Yoo CH, Kim HK, Han MK. NAADP mediates insulin-stimulated glucose uptake and insulin sensitization by PPAR gamma in adipocytes. Cell Rep. 2012;2(6):1607–19.View ArticlePubMedGoogle Scholar
  43. Choi SS, Cha BY, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci. 2009;84(25–26):908–14.View ArticlePubMedGoogle Scholar
  44. Anand P, Murali KY, Tandon V, Murthy PS, Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem Biol Interact. 2010;186(1):72–81.View ArticlePubMedGoogle Scholar
  45. Ha DT, Trung TN, Phuong TT, Yim N, Chen QC, Bae K. The selected flavonol glycoside derived from Sophorae flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells. Bioorg Med Chem Lett. 2010;20(20):6076–81.View ArticleGoogle Scholar
  46. Choi JH, Banks AS, Kameneck TM, Busby SA, Chalmers MJ, Kumar N, Griffin PR. Antidiabetic actions of a non-agonist PPAR gamma ligand blocking Cdk5-mediated phosphorylation. Nature. 2011;477(7365):477–U131.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement